Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Gastric Cancer|Colon Cancer|Rectal Cancer|Breast Cancer|Lung Cancer|Esophagus Cancer|Cholangiocarcinoma|Pancreas Cancer
Interventions: BIOLOGICAL: CEA-targeted CAR-T cells|BIOLOGICAL: CEA-targeted CAR-T cells
Sponsor: Chongqing Precision Biotech Co., Ltd
Collaborators: First Affiliated Hospital of Wannan Medical College